STOCK TITAN

BlackRock ESG Capital Allocation Term SEC Filings

ECAT NYSE

Welcome to our dedicated page for BlackRock ESG Capital Allocation Term SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The SEC filings page for BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) brings together the fund’s regulatory disclosures as a non-diversified, closed-end management investment company. As a registered investment company, ECAT files documents with the U.S. Securities and Exchange Commission that describe its structure, investment objectives, governance, and material corporate actions.

Regulatory materials referenced in public announcements include tender offer statements on Schedule TO, proxy statements for annual meetings, and related exhibits. Tender offer documents outline the terms under which ECAT has offered to repurchase a portion of its outstanding common shares, including the percentage of shares subject to the offer and the method for determining the purchase price as a percentage of net asset value on a specified date.

Proxy statements and associated filings provide details on proposals submitted to shareholders, such as the election of trustees and a shareholder proposal to terminate BlackRock Advisors, LLC as investment adviser. These filings also form the basis for recommendations issued by proxy advisory firms Institutional Shareholder Services, Glass Lewis, and Egan-Jones, which are discussed in Business Wire releases.

Litigation involving ECAT’s voting bylaws, brought by Saba Capital Management, L.P., is also connected to the fund’s regulatory framework under the Investment Company Act. Court rulings described in public news highlight questions about how ECAT’s voting standards interact with statutory requirements for shareholder elections and board composition.

On Stock Titan, ECAT’s SEC filings are supplemented with AI-powered summaries that explain the key points of lengthy documents in plain language. Real-time updates from the SEC’s EDGAR system allow users to see new filings as they appear, while AI-generated highlights help identify important items in tender offer statements, proxy materials, and other disclosures. This structure enables investors to review ECAT’s regulatory history, advisory arrangements, and governance-related filings more efficiently.

Rhea-AI Summary

Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust, reported two open-market sales of the trust’s common stock. It sold 34,797 shares on February 24, 2026 at an average price of $15.09 per share and 59,356 shares on February 25, 2026 at an average price of $15.27 per share.

After these transactions, Saba Capital indirectly held 23,575,057 shares of common stock, reflecting a net sale of 94,153 shares across the two days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of fund common stock. On February 19 and 20, 2026, it sold a total of 75,148 shares at prices of $15.03 and $15.07 per share. Following the latest transaction, it indirectly owned 23,669,210 shares of ECAT common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management and affiliates report a significant activist stake in BlackRock ESG Capital Allocation Term Trust, beneficially owning 23,744,358 common shares, or 23.9% of the class, based on 99,345,793 shares outstanding as of June 30, 2025.

Saba states that approximately $352,969,830 was paid to acquire these shares, funded by investor subscription proceeds, related capital appreciation, and ordinary-course margin borrowings. The shares are held in funds and accounts advised by Saba, which have rights to dividends and sale proceeds.

On February 18, 2026, a Saba-advised fund submitted a notice to nominate a slate of seven independent trustee candidates for election at the Issuer’s 2026 annual shareholder meeting, covering multiple board classes. Each nominee has entered into a nomination agreement with Saba that includes defense and indemnification related to potential litigation arising from their nominations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. It sold 113,401 shares on February 17 at $15.06 per share and 45,888 shares on February 18 at $15.11 per share, totaling 159,289 shares. After these indirect transactions, it reported owning 23,744,358 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported open-market sales of ECAT common stock. On February 12, 2026 it sold 234,005 shares at $15.47 per share, followed by 50,600 shares at $15.22 per share on February 13, 2026.

These transactions were reported as indirect ownership. After the February 13, 2026 sale, Saba Capital Management, L.P. reported beneficial ownership of 23,903,647 ECAT common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of 156,858 shares of common stock on February 11, 2026 at $15.60 per share. After this indirect sale, it beneficially owned 24,188,252 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. On February 9, 2026, it sold 96,973 shares at $15.55 per share. On February 10, 2026, it sold a further 64,101 shares at $15.60 per share.

After these transactions, Saba Capital Management, L.P. indirectly beneficially owned 24,345,110 shares of ECAT common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On February 5, 2026, it sold 131,090 shares at $15.11 per share. On February 6, 2026, it sold an additional 36,044 shares at $15.29 per share.

After these transactions, Saba Capital Management, L.P. beneficially owned 24,506,184 ECAT common shares, held indirectly. The filing reflects portfolio activity by a large shareholder rather than any change in the issuer’s business operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management and affiliates report a significant ownership position in BlackRock ESG Capital Allocation Term Trust. They disclose beneficial ownership of 24,673,318 common shares, representing 24.84% of the fund’s outstanding shares, based on 99,345,793 shares outstanding as of June 30, 2025.

The filing, Amendment No. 27 to a Schedule 13D, is jointly made by Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein. All reported shares are held with shared voting and dispositive power through funds and accounts advised by Saba Capital.

Saba states that approximately $366,779,210 was paid to acquire these shares, using investor subscription proceeds, capital appreciation and margin borrowings in the ordinary course, with all recent trades executed in the open market. The amendment specifically updates information on funding, ownership details and the transaction schedule.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported two sales of ECAT common stock. On February 3, 2026, it sold 143,707 shares at $15.38 per share, leaving 24,824,510 shares indirectly beneficially owned. On February 4, 2026, it sold another 151,192 shares at $15.28 per share, leaving 24,673,318 shares indirectly beneficially owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of BlackRock ESG Capital Allocation Term (ECAT)?

The current stock price of BlackRock ESG Capital Allocation Term (ECAT) is $13.9 as of March 13, 2026.

What is the market cap of BlackRock ESG Capital Allocation Term (ECAT)?

The market cap of BlackRock ESG Capital Allocation Term (ECAT) is approximately 1.4B.

ECAT Rankings

ECAT Stock Data

1.45B
99.35M
Asset Management
Financial Services
Link
United States
New York

ECAT RSS Feed